CA2158427A1 - Methodes et compositions pour le controle de la traduction des proteinesde vhc - Google Patents

Methodes et compositions pour le controle de la traduction des proteinesde vhc

Info

Publication number: CA2158427A1
Authority: CA; Canada
Prior art keywords: compositions; methods; hcv proteins; controlling translation; translation
Prior art date: 1992-09-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA002158427A

Other languages

English (en)

Other versions

CA2158427C (fr

Inventor

Jan H. Hang

Richard R. Spaete

Byoung J. Yoo

Byung S. Suh

Mark J. Selby

Michael Houghton

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis Vaccines and Diagnostics Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-28

Filing date

1993-09-28

Publication date

1994-03-29

1993-09-28 Application filed by Individual filed Critical Individual

1993-09-28 Priority claimed from CA002145290A external-priority patent/CA2145290C/fr

1994-03-29 Publication of CA2158427A1 publication Critical patent/CA2158427A1/fr

2002-09-17 Application granted granted Critical

2002-09-17 Publication of CA2158427C publication Critical patent/CA2158427C/fr

2013-09-28 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 2
108090000623 proteins and genes Proteins 0.000 title abstract 2
230000003612 virological effect Effects 0.000 abstract 3
241000710778 Pestivirus Species 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

CA002158427A 1992-09-28 1993-09-28 Methodes et compositions pour le controle de la traduction des proteinesde vhc Expired - Lifetime CA2158427C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US95279992A	1992-09-28	1992-09-28
US07/952,799		1992-09-28
CA002145290A CA2145290C (fr)	1992-09-28	1993-09-28	Methodes et compositions pour la regulation de la traduction des proteines du vhc

Publications (2)

Publication Number	Publication Date
CA2158427A1 true CA2158427A1 (fr)	1994-03-29
CA2158427C CA2158427C (fr)	2002-09-17

Family

ID=25677855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002158427A Expired - Lifetime CA2158427C (fr)	1992-09-28	1993-09-28	Methodes et compositions pour le controle de la traduction des proteinesde vhc

Country Status (1)

Country	Link
CA (1)	CA2158427C (fr)

1993
- 1993-09-28 CA CA002158427A patent/CA2158427C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2158427C (fr)	2002-09-17

Similar Documents

Publication	Publication Date	Title
CA2145290A1 (fr)	1994-04-14	Methodes et compositions pour la regulation de la traduction des proteines du vhc
AU4880093A (en)	1994-04-21	Retrovirus from the HIV group and its use
AU4978496A (en)	1996-09-04	Encapsidated recombinant poliovirus nucleic acid
CA2116764A1 (fr)	1993-04-01	Compositions de polypeptides du virus de l'hepatite c immunoreactives
CA2108466A1 (fr)	1992-11-09	Sequences genomiques du vhc pour le diagnostic et la therapie
AU2663197A (en)	1997-10-29	Modulation of mammalian telomerase by peptide nucleic acids
CA2127541A1 (fr)	1993-07-22	Virus recombinant de la variole porcine
AU8700291A (en)	1992-05-07	Hcv-specific peptides, agents therefor and the use thereof
CA2318030A1 (fr)	1999-07-29	Adn et polypeptides acpl
EP0992580A3 (fr)	2000-08-09	Epitopes de lymphocytes T humains immunodominants du virus de l'hépatite C
AU681705B2 (en)	1997-09-04	Endosomolytically active particles
CA2241174A1 (fr)	1997-07-17	Elements de sequence augmentant l'expression pour systemes d'expression d'eucaryotes
AU3487697A (en)	1998-01-07	Use of chimeric vaccinia virus complement control proteins to inhibit complement
CA2011878A1 (fr)	1990-09-10	Regions immunogenes sur la proteine e7 du papillomavirus humain de type 16
AU2197392A (en)	1993-02-11	Hepatitis C virus from C-100-3 and env/core regions
AU7473294A (en)	1995-02-20	Stabilization of aerosolized proteins
AU7602800A (en)	2001-04-24	Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
EP1681350A3 (fr)	2007-07-18	Polypeptides et polynucleotides de Phorphorymonas gingivalis
WO1994013812A3 (fr)	1994-11-10	Nouveaux genes de l'entomopoxvirus, nouvelles proteines et leurs procedes d'utilisation
AU7691191A (en)	1991-11-11	Recombinant spider silk proteins through genetic engineering
AU6292694A (en)	1994-10-24	Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
CA2040441A1 (fr)	1991-02-26	Proteines de fusion
HUP9802587A3 (en)	1999-12-28	Glucose-inducible recombinant viral vector, pharmaceutical composition containing it and cells transformed by this
CA2158427A1 (fr)	1994-03-29	Methodes et compositions pour le controle de la traduction des proteinesde vhc
AU6157996A (en)	1996-12-30	Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus

Legal Events

Date	Code	Title	Description
1996-07-19	EEER	Examination request